Experience with enteral sulfonylurea monotherapy for extremely low birth weight infants with hyperglycemia-Reference-Cited by-同舟云学术

Experience with enteral sulfonylurea monotherapy for extremely low birth weight infants with hyperglycemia

Published:2022 Issue:4 Volume:31 Page:225-233
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Nakagawa Ai¹,Hirano Daishi²,Inage Yuka²,Yamada Saya²,Kotake Yuko²,Ikoma Naohiro²,Kumazawa Kensuke²,Hayashi Shion²,Tanabe Yukitoshi²,Kobayashi Masahisa²,Shimizu Masaki³

Affiliation:

1. Department of Pediatrics, Machida Municipal Hospital, Tokyo, Japan

2. Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan

3. Division of Neonatology, Saitama Children’s Medical Center, Saitama, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/31/4/31_2022-0018/_pdf

Reference33 articles.

1. 1. Hays, SP, Smith, EO, Sunehag, AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118: 1811–8.

2. 2. Blanco, CL, Baillargeon, JG, Morrison, RL, Gong, AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006;26: 737–41.

3. 3. Soghier, LM, Brion, LP. Multivariate analysis of hyperglycemia in extremely low birth weight infants. J Perinatol 2006;26: 723–5.

4. 4. Kao, LS, Morris, BH, Lally, KP, Stewart, CD, Huseby, V, Kennedy, KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;26: 730–6.

5. 5. Decaro, MH, Vain, NE. Hyperglycaemia in preterm neonates: what to know, what to do. Early Hum Dev 2011;87(Suppl 1): S19–22.